Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedTech Dental (MTD) is a Swiss dental healthcare company founded in 2013 that specializes in the development and commercialization of innovative, minimally invasive, and topical treatments for oral health. The company's portfolio focuses on localized therapies that reduce the need for systemic antibiotics and minimize patient discomfort. Key products include Gelcide, a bioadhesive gel containing piperacillin and tazobactam for periodontitis; Implaprotect and Implacure, which are targeted antimicrobial and regenerative systems for peri-implant mucositis and peri-implantitis; and Bone Hyal, a high-density hyaluronic acid formulation designed to accelerate bone and soft tissue regeneration. MTD's products are distributed globally through partnerships with specialized dental distributors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedTechDental.